Cite
MLA Citation
A Borghetti et al.. “Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication.” HIV medicine, vol. 19, no. 7, 2018, pp. 452–454. http://access.bl.uk/ark:/81055/vdc_100066549953.0x00001c